company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,16173000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,40291000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,23000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1224000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,57711000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4884000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3639000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3639000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,,totalassets,Total Assets,=,debit,usd,66234000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,812000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6008000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,23322000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,339000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,30481000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,14917000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,18000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,14935000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,45416000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,182773000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4627000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-166597000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,15000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-161955000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-161955000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-161955000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,,2013-06-30,2013-09-03 06:31:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,66234000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,11092000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,117554000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,10023000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1929000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,140598000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4569000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,43000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,43000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,,totalassets,Total Assets,=,debit,usd,145210000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2101000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6865000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,23336000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,10000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,32312000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,11828000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,16000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,11844000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,44156000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,271119000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-170082000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,17000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,101054000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,101054000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,101054000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,,2013-09-30,2013-11-13 16:03:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,145210000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,25950000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,257963000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,23000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2502000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,286438000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4962000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10486000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,10486000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,,totalassets,Total Assets,=,debit,usd,301886000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2935000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10064000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,35696000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,10000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,48705000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,147353000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,11000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,147364000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,196069000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,294143000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-188297000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-29000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,105817000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,105817000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,105817000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,,2014-03-31,2014-05-08 06:08:16+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,301886000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,23379000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,242969000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,71000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2784000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,269203000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5168000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,9933000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,9933000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,,totalassets,Total Assets,=,debit,usd,284304000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3033000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12062000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,35276000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,10000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,50381000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,141612000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,8000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,141620000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,192001000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,296208000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-203894000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-11000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,92303000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,92303000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,92303000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,,2014-06-30,2014-08-07 08:01:14+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,284304000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,29995000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,217878000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2072000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3573000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,2562000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,256080000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4965000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,7895000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,7895000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,,totalassets,Total Assets,=,debit,usd,268940000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3795000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15197000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,21851000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,10000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,40853000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,138658000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,138664000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,179517000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,298769000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-209380000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,34000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,89423000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,89423000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,89423000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,,2014-09-30,2014-11-04 16:16:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,268940000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,29115000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,183933000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,15000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1799000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,7102000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,221964000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5119000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1925000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1925000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,,totalassets,Total Assets,=,debit,usd,229008000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3073000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13092000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,18329000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,10000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,34504000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,129179000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,129181000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,163685000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,304213000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-238965000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,75000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,65323000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,65323000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,65323000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,,2015-03-31,2015-05-07 16:47:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,229008000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,36255000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,163973000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1162000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,201399000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5349000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2333000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2333000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,,totalassets,Total Assets,=,debit,usd,209081000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6143000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13955000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,17233000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,9000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,37340000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,125430000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,125430000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,162770000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,306792000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-260585000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,104000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,46311000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,46311000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,46311000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,,2015-06-30,2015-08-10 16:28:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,209081000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,31280000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,143925000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,315000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1785000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,177305000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5065000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2204000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2204000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,,totalassets,Total Assets,=,debit,usd,184574000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3441000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,18424000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,15825000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,37697000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,121992000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,121992000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,159689000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,309826000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-285065000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,124000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,24885000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,24885000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,24885000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,,2015-09-30,2015-11-05 16:30:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,184574000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,84563000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,108940000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1308000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3565000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,198376000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4907000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1647000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1647000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,,totalassets,Total Assets,=,debit,usd,204930000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3212000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,23078000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,22146000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,48438000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,176303000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,176303000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,224741000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,317110000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-337056000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,135000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-19811000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-19811000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-19811000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,,2016-03-31,2016-05-05 16:34:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,204930000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,37771000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,133756000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2021000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2534000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,176082000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4643000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1168000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1168000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,,totalassets,Total Assets,=,debit,usd,181893000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4451000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,28062000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,21826000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,54339000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,171093000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,171093000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,225432000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,321044000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-364745000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,162000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-43539000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-43539000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-43539000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,,2016-06-30,2016-08-09 16:45:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,181893000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,30084000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,177506000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2248000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2836000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,212674000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4355000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1159000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1159000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,,totalassets,Total Assets,=,debit,usd,218188000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5436000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,28463000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,21582000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,55481000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,165888000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,165888000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,221369000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,387238000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-390610000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,191000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-3181000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-3181000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-3181000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,,2016-09-30,2016-11-01 16:24:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,218188000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39195000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,117740000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1652000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3203000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,161790000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4172000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,984000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,984000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,,totalassets,Total Assets,=,debit,usd,166946000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3910000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,25368000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,20192000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,49470000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,158248000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,158248000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,207718000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,394513000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-435553000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,268000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-40772000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-40772000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-40772000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,,2017-03-31,2017-05-08 16:44:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,166946000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,31940000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,97828000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1990000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3220000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,134978000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3783000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,584000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,584000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,,totalassets,Total Assets,=,debit,usd,139345000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2115000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17694000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,20053000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,39862000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,153270000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,153270000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,193132000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,396720000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-450779000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,272000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-53787000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-53787000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-53787000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,,2017-06-30,2017-08-02 16:16:42+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,139345000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,15877000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,97710000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,348000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2430000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,116365000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3368000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,748000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,748000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,,totalassets,Total Assets,=,debit,usd,120481000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,779000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13514000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,20053000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,34346000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,148290000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,148290000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,182636000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,399140000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-461470000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,175000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-62155000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-62155000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-62155000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,,2017-09-30,2017-11-02 16:29:27+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,120481000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,14125000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,74299000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,258000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1669000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,90351000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2934000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1846000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1846000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,,totalassets,Total Assets,=,debit,usd,95131000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,704000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6242000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,27919000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,34865000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,13934000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,13934000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,48799000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,405435000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-359259000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,156000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,46332000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,46332000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,46332000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,,2018-03-31,2018-05-08 16:16:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,95131000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,10561000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,69305000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,110000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1493000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,81469000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2532000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1908000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1908000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,,totalassets,Total Assets,=,debit,usd,85909000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,981000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6337000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,25908000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,33226000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,8708000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,8708000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,41934000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,407267000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-363235000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-57000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,43975000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,43975000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,43975000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,,2018-06-30,2018-08-02 08:46:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,85909000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8406000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,62450000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,416000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1913000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,73185000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2362000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1606000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1606000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,,totalassets,Total Assets,=,debit,usd,77153000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3163000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6898000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,11278000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21339000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4090000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4090000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,25429000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,408906000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-357120000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-62000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,51724000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,51724000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,51724000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,,2018-09-30,2018-11-01 16:21:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,77153000.0
